{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:55:29Z","timestamp":1761310529909},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.intimp.2008.11.007","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T09:42:13Z","timestamp":1230284533000},"page":"284-290","source":"Crossref","is-referenced-by-count":9,"title":["P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: Clinical implications and influence of glucocorticoid administration"],"prefix":"10.1016","volume":"9","author":[{"given":"Sachiko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.11.007_bib1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vicent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2008.11.007_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI113807","article-title":"In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes","volume":"82","author":"Brocke","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2008.11.007_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI113729","article-title":"A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis","volume":"82","author":"Harcourt","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2008.11.007_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/eji.1830250509","article-title":"Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats","volume":"25","author":"Zhang","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2008.11.007_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00863771","article-title":"Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression","volume":"241","author":"Crosti","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.intimp.2008.11.007_bib6","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/archneur.64.12.1792","article-title":"Immunosuppressive or surgical treatment for ocular Myasthenia Gravis","volume":"64","author":"Chavis","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.intimp.2008.11.007_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mus.1220","article-title":"Steroid treatment for myasthenia gravis: steroids are overutilized","volume":"25","author":"Rivner","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2008.11.007_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0006-291X(86)80136-X","article-title":"The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein","volume":"141","author":"Ueda","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2008.11.007_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","article-title":"Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes","volume":"80","author":"Chaudhary","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2008.11.007_bib10","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.11.007_bib11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.leu.2400656","article-title":"Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-H\u00f4pitaux de Paris","volume":"11","author":"Marie","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2008.11.007_bib12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V86.6.2329.bloodjournal8662329","article-title":"Correlation of multidrug resistance (MDR1) protein expression with functionaldye\/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-\/efflux+ and MDR1+\/efflux-cases","volume":"86","author":"Leith","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2008.11.007_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1992.tb04608.x","article-title":"Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123","volume":"82","author":"Ludescher","year":"1992","journal-title":"Br Haematol"},{"key":"10.1016\/j.intimp.2008.11.007_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopha.2004.04.008","article-title":"Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients","volume":"58","author":"Yvonne","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.intimp.2008.11.007_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/rheumatology\/35.5.430","article-title":"Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone","volume":"35","author":"Maillefert","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.intimp.2008.11.007_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0091270004264162","article-title":"MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration","volume":"44","author":"Hirano","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.intimp.2008.11.007_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2008.11.007_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0009-9236(98)90042-X","article-title":"Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis","volume":"63","author":"Hirano","year":"1998","journal-title":"Clin Pharmcol Ther"},{"key":"10.1016\/j.intimp.2008.11.007_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.106.110155","article-title":"Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody","volume":"320","author":"Goda","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2008.11.007_bib20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/01.TP.0000131163.43015.85","article-title":"P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection","volume":"77","author":"Donnenberg","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2008.11.007_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cyto.a.10114","article-title":"Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets","volume":"57","author":"Donnenberg","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.intimp.2008.11.007_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/25.7.894009","article-title":"Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources","volume":"25","author":"Young","year":"1977","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.intimp.2008.11.007_bib23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2008.11.007_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.0300-9475.2005.01546.x","article-title":"Distinct leucocyte redistribution after glucocorticoid treatment among difficult to treat asthmatic patients","volume":"61","author":"Karagiannidis","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2008.11.007_bib25","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1681\/ASN.V12suppl_1s48","article-title":"Steroid-resistant kidney transplant rejection: diagnosis and treatment","volume":"12","author":"Bock","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2008.11.007_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2008.11.007_bib27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V88.5.1747.1747","article-title":"Involvement of P-glycoprotein in the transmembrane transport of interleukin-2(IL-2), IL-4, and interferon- gamma in normal human T lymphocytes","volume":"88","author":"Drach","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2008.11.007_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1365-2443.2004.00803.x","article-title":"Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes","volume":"9","author":"Tsujimura","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.intimp.2008.11.007_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.placenta.2007.05.001","article-title":"Examination of Glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines","volume":"28","author":"Pavek","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.intimp.2008.11.007_bib30","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","article-title":"Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes","volume":"80","author":"Chaudhary","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2008.11.007_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas (CD95)\/FasL interactions required for programmed cell death after T-cell activation","volume":"373","author":"Ju","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.11.007_bib32","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.181.5.1673","article-title":"Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas:inhibition of Fas ligand expression by retinoic acid and glucocorticoids","volume":"181","author":"Yang","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2008.11.007_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1023\/A:1013177710941","article-title":"Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival","volume":"21","author":"Gollapud","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.intimp.2008.11.007_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00918857","article-title":"Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function","volume":"12","author":"Gupta","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.intimp.2008.11.007_bib35","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2008.11.007_bib36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/01.wnl.0000218665.94920.5e","article-title":"Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis","volume":"66","author":"Sanders","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2008.11.007_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.2005.00378.x","article-title":"Cyclosporine in the treatment of myasthenia gravis","volume":"111","author":"Lavrnic","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.intimp.2008.11.007_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1248\/bpb.30.291","article-title":"P-glycoprotein function in peripheral blood mononuclear cells of myasthenia gravis patients treated with tacrolimus","volume":"30","author":"Tanaka","year":"2007","journal-title":"Biol Pharm Bull"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908003494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908003494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T21:52:24Z","timestamp":1632865944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908003494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1567576908003494"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.11.007","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}